ADDRESS & CONTACT
Address
156 Valleyview Road , Kelowna, BC V1X3M4, Canada
GPS
49.888665, -119.393631
Telephone
OPENING HOURS
Monday
–
Tuesday
–
Wednesday
–
Thursday
–
Friday
–
Saturday
–
Sunday
–
Lexaria Corp is a food sciences company focused on the delivery of CBD through gourmet foods. Lexaria owns two patent-pendings for delivery of CBD or THC infused within lipids. This exclusive technology is theorized to result in more efficient and comforting delivery of active ingredients.
Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October, 2016. Lexaria’s technology provides increases of up to 10x in intestinal absorption rates; more rapid delivery to the bloodstream with effects often within 15-20 minutes; and important taste-masking benefits, for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.
Lexaria Bioscience Corp. evolved into its current form in 2014 upon controlling acquisition of the former company where Lexaria’s DehydraTECH(TM) technology originated. Since then, Lexaria has quickly emerged as a global leader in enhancing the flavor, bouquet and gastro-intestinal delivery of edible cannabinoid consumer products while also working to expand the applicability of its technology, within and beyond the cannabinoid sector, through its out-licensing business model for cannabinoids and other bioactive molecules named in its patent portfolio (NSAIDs, nicotine, vitamins and more). Lexaria produces industry-leading research to support its novel delivery method. None of this can happen without the talented and dedicated people who have supported Lexaria’s development and growth.
Lexaria has always maximized its resources by attracting top management and advisors and also leveraging the strongest expert consultant relationships. Supporters have included industry leaders, research scientists, clinicians, analytical chemists, intellectual property experts, study volunteers, partnering company collaborators and, of course, the original inventors of the earliest iterations of Lexaria’s DehydraTECH(TM) technology.